Researchers find that moderate stress levels are associated with a 78% increased risk of unexplained strokes in women under 50, potentially offering new insights for prevention strategies in this demographic.
Researchers will present findings at the American Academy of Neurology’s 77th Annual Meeting on how OTC pain relievers may be linked to faster concussion recovery.
February's FDA approvals feature advancements in cardiology, neurology, infectious diseases, and rare disorders, including the first trials for genetically modified pig kidney transplants and novel treatments for Parkinson’s disease and spinal muscular atrophy.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Individuals with androgenetic alopecia face an increased risk of depression, with an odds ratio of 1.015, according to a new Mendelian randomization study.
The FDA has approved tenecteplase for acute ischemic stroke, offering a faster and simpler administration compared to alteplase based on findings from the AcT trial.